Seoul, South Korea

Eunice Eun-Kyeong Kim


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Eunice Eun-Kyeong Kim: Innovator in Pharmaceutical Science

Introduction

Eunice Eun-Kyeong Kim is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds for treating various diseases. With a total of 6 patents to her name, her work has the potential to impact the medical community significantly.

Latest Patents

Among her latest patents is a groundbreaking invention related to oxazolidinone derivatives. This invention focuses on a pharmaceutical composition for preventing or treating hepatitis C, utilizing oxazolidinone compounds represented by Chemical Formula 1. Another notable patent involves benzoarylureido compounds, which are aimed at preventing and treating neurodegenerative brain diseases such as Alzheimer's disease, dementia, and Parkinson's disease. These innovations highlight her commitment to addressing critical health challenges.

Career Highlights

Eunice Eun-Kyeong Kim is affiliated with the Korea Institute of Science and Technology, where she conducts her research and development. Her work at this esteemed institution has allowed her to explore various avenues in pharmaceutical innovation, contributing to her impressive portfolio of patents.

Collaborations

Throughout her career, Eunice has collaborated with notable colleagues, including Key-Sun Kim and Gyo Chang Keum. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Eunice Eun-Kyeong Kim stands out as a dedicated inventor in the pharmaceutical field, with her innovative patents addressing significant health issues. Her contributions continue to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…